Investigating immune responses using advanced sequencing techniques.
Official title: Core C: IgSeq and NGS Core
Funded at Boston Children's Hospital · NIH-11290936 · Data updated 2026-11-12
This study is looking at how your immune system works by using new technology to analyze your immune responses, which could help us better understand and treat immune-related conditions.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | April 1, 2025 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $347,000 |
| NIH project number | 5P01AI089618-13 |
| Project ID | NIH-11290936 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with immune system disorders or those interested in understanding their immune responses.
✕Less likely to help
Patients without any immune-related conditions or those not interested in immune system research may not benefit from this research.
What this research studies
This research focuses on utilizing advanced sequencing technologies to analyze immune responses in patients. By employing innovative methods such as IgSeq and next-generation sequencing (NGS), the research aims to provide insights into how the immune system functions and responds to various conditions. Patients may benefit from this research as it could lead to improved understanding and treatment of immune-related disorders. The approach involves collecting and analyzing biological samples to uncover critical data about immune system behavior.
Why it matters
Potential benefit: If successful, this research could enhance the understanding of immune responses, leading to better treatments for immune-related conditions.
How similar studies have gone: Other research utilizing advanced sequencing techniques has shown promise in understanding immune responses, indicating that this approach is supported by previous successes.
Where this research is happening
-
Boston Children's Hospital
Boston, United States Active
Researchers
- Principal investigator: Lee, Jiwon — Boston Children's Hospital
- Study coordinator: Lee, Jiwon
Related research
Other NIH-funded projects on the same topics.
-
Targeting the brain’s fluid system to treat post-hemorrhagic hydrocephalus
This grant explores a new approach to treating post-hemorrhagic hydrocephalus by studying how the brain’s fluid system and immune cells manage CSF after a brain bleed.
-
National Spina Bifida Patient Registry at Boston Children’s Hospital
A patient-focused registry project at Boston Children’s Hospital will collect and study information from people with spina bifida to improve care and outcomes.
-
Severe Chronic Neutropenia Registry for Patients
A patient-facing registry that tracks severe chronic low neutrophil counts to improve understanding and care for people with this condition.
-
Severe Chronic Neutropenia Registry to Improve Care
A patient-focused registry gathers information from adults with severe chronic neutropenia to better understand infections, treatments, and outcomes over time.
-
Severe Chronic Neutropenia Registry: Finding Better Ways to Prevent Infections
A patient-focused registry at a leading hospital helps people with severe chronic neutropenia learn how the condition progresses and how treatments work over time.
-
Exploring epilepsy genes in zebrafish to understand human brain seizures
A study in zebrafish will model human epilepsy genes to help explain how certain brain mutations contribute to seizures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.